Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilazodone in PTSD
NCT05948579Phase 2Not yet recruiting
- Sponsor
- Global Coalition for Adaptive Research
- Start
- Aug 2027
- Primary completion
- May 2028
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of vilazodone in post-traumatic stress disorder (PTSD), sponsored by Global Coalition for Adaptive Research. Planned start Aug 2027; status: not yet recruiting.
02
Drugs
vilazodone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT05948579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05948579.